Evidence map›Paper›PMID 34420148›Full record

ReviewMolecular biology reports2021

Lipoic acid. Kinetics and pluripotent biological properties and derivatives.

Panagiotis Theodosis-Nobelos, Georgios Papagiouvannis, Paraskevi Tziona, Eleni A Rekka

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Cuproptosis Related GeneCurrent cancer drug targets · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Panagiotis Theodosis-NobelosDepartment of Pharmacy, School of Health Sciences, Frederick University, 1036, Nicosia, Cyprus. hsc.np@frederick.ac.cy.ORCID http://orcid.org/0000-0003-3153-6425
Georgios PapagiouvannisDepartment of Pharmacy, School of Health Sciences, Frederick University, 1036, Nicosia, Cyprus.
Paraskevi TzionaDepartment of Pharmaceutical Chemistry, School of Pharmacy, Aristotelian University of Thessaloniki, 54124, Thessaloniki, Greece.
Eleni A RekkaDepartment of Pharmaceutical Chemistry, School of Pharmacy, Aristotelian University of Thessaloniki, 54124, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRFrederick University · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipoic acid (LA) is globally known and its supplements are widely used. Despite its importance for the organism it is not considered a vitamin any more. The multiple metabolic forms and the differences in kinetics (absorption, distribution and excretion), as well as the actions of its enantiomers are analysed in the present article together with its biosynthetic path. The proteins involved in the transfer, biotransformation and activity of LA are mentioned. Furthermore, the safety and the toxicological profile of the compound are commented, together with its stability issues. Mechanisms of lipoic acid intervention in the human body are analysed considering the antioxidant and non-antioxidant characteristics of the compound. The chelating properties, the regenerative ability of other antioxidants, the co-enzyme activity and the signal transduction by the implication in various pathways will be discussed in order to be elucidated the pleiotropic effects of LA. Finally, lipoic acid integrating analogues are mentioned under the scope of the multiple pharmacological actions they acquire towards degenerative conditions.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsAntipsychotic AgentsChelating AgentsDietary SupplementsHumansHypnotics and SedativesHypoglycemic AgentsImmunomodulating AgentsKineticsOxidation-ReductionSignal TransductionThioctic AcidAnti-Inflammatory AgentsAntioxidantsAntipsychotic AgentsChelating AgentsHypnotics and SedativesHypoglycemic AgentsImmunomodulating AgentsThioctic AcidLipoic acidMetabolism of lipoic acidNeuroprotective derivativesProperties of lipoic acid

Identifiers

PMID34420148
OpenAlexW3193390929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.